Date: Sun 01/09/2019 - Sat 31/10/2020
Provider: Luxottica Institute of Learning
Optometrist Credits: 0.50 General Credits
Event Type(s): Online
Number: 09 929 3274
This article provides an overview of unmet needs in the treatment of neovascular age-related macular degeneration (nAMD) including how the burden of treatment may lead to patients stopping therapy. Approaches to minimising the treatment burden and improving patient outcomes are also discussed.
- Gain an improved understanding of the unmet needs of Australian patients with nAMD
- Be able to consider the impact of factors that contribute to nAMD treatment discontinuation, including:Treatment-related anxiety; Economic considerations; Travel considerations; Caregiver burden; Older age and comorbidities; Poor clinical response and unmet expectation.
- Be able to identify and evaluate ways to reduce the treatment burden in nAMD in Australia